Helsinn to present a scientific poster on acute care use following CINV prophylaxis with agents in breast cancer patients at the San Antonio Breast Cancer Symposium (SABCS) 2019

16 December 2019

FDA grants Orphan Drug Designation to APR Applied Pharma Research’s Investigational Drug for the Treatment of Epidermolysis Bullosa

4 December 2019

3° trimestre 2019: industria farmaceutica ed energia guidano la crescita del PIL

28 November 2019

Helsinn Advanced Synthesis, Biasca: Reduces CO2 emissions by 80% and unveils the new anticancer plant

22 November 2019

Helsinn supported ‘70 Years of Cancer Care in China’ celebratory event in Shanghai

14 November 2019

Farma Industria Ticino in Frankfurt for CPhI Worldwide 2019

8 November 2019

Helsinn attends 4th Annual Sino-Swiss Business Awards

7 November 2019

La RSI in visita presso alcune aziende industriali del nostro territorio

29 October 2019

Helsinn to co-host alongside Recordati Rare Diseases satellite symposium on MF-CTCL diagnosis optimization at European Academy of Dermatology and Venereology Congress 2019

9 October 2019

Comunicato stampa “Farma Industria Ticino and Credit Suisse Award for best student”, mercoledì 18 settembre 2019

19 September 2019